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Sonia Fernández-Veledo 1,2,*,12ABSTRACT
Objective: Glycogen metabolism has emerged as a mediator in the control of energy homeostasis and studies in murine models reveal that
adipose tissue might contain glycogen stores. Here we investigated the physio(patho)logical role of glycogen in human adipose tissue in the
context of obesity and insulin resistance.
Methods: We studied glucose metabolic flux of hypoxic human adipoctyes by nuclear magnetic resonance and mass spectrometry-based
metabolic approaches. Glycogen synthesis and glycogen content in response to hypoxia was analyzed in human adipocytes and macro-
phages. To explore the metabolic effects of enforced glycogen deposition in adipocytes and macrophages, we overexpressed PTG, the only
glycogen-associated regulatory subunit (PP1-GTS) reported in murine adipocytes. Adipose tissue gene expression analysis was performed on wild
type and homozygous PTG KO male mice. Finally, glycogen metabolism gene expression and glycogen accumulation was analyzed in adipose
tissue, mature adipocytes and resident macrophages from lean and obese subjects with different degrees of insulin resistance in 2 independent
cohorts.
Results: We show that hypoxia modulates glucose metabolic flux in human adipocytes and macrophages and promotes glycogenesis. Enforced
glycogen deposition by overexpression of PTG re-orients adipocyte secretion to a pro-inflammatory response linked to insulin resistance and
monocyte/lymphocyte migration. Furthermore, glycogen accumulation is associated with inhibition of mTORC1 signaling and increased basal
autophagy flux, correlating with greater leptin release in glycogen-loaded adipocytes. PTG-KO mice have reduced expression of key inflammatory
genes in adipose tissue and PTG overexpression in M0 macrophages induces a pro-inflammatory and glycolytic M1 phenotype. Increased
glycogen synthase expression correlates with glycogen deposition in subcutaneous adipose tissue of obese patients. Glycogen content in
subcutaneous mature adipocytes is associated with BMI and leptin expression.
Conclusion: Our data establish glycogen mishandling in adipose tissue as a potential key feature of inflammatory-related metabolic stress in
human obesity.
 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Original article1. INTRODUCTION
Adipose tissue is a highly complex metabolic organ with essential roles
in handling and storing excess nutrients and preventing ectopic lipid
accumulation in other organs. Excess lipid storage in adipose tissue
leads to changes in its metabolic and endocrine functions, resulting in
the generation of stress signals and the derangement of carbohydrate
metabolism, among others [1]. In this setting, not only adipocytes but
also infiltrating adipose tissue macrophages (ATMs), among other
immune cells, participate in the chronic low-grade inflammation that
occurs in the adipose tissue of obese individuals [2].
While triglyceride stored in adipose tissue is considered the principal
energy reserve in mammals, glucose can also be stored as glycogen,
primarily in liver and skeletal muscle, for mobilization during times of
energy deficit. In humans, hepatic and skeletal muscle glycogen
deposition is decreased under pathologic conditions associated with
obesity, such as insulin resistance and type 2 diabetes [3e7], and is a
hallmark of metabolic stress.
Glycogen synthesis is dynamically regulated by insulin through coor-
dinated dephosphorylation of the key glycogenic enzyme glycogen
synthase (GS) by the serine/threonine phosphatase PP1, which results
in its activation, and the glycogenolytic enzyme glycogen phosphory-
lase (GP), which is inactivated [8]. The PP1 catalytic subunit (PP1c) is
targeted to glycogen particles by glycogen-associated targeting sub-
units (PP1-GTS), including PPP1R3A (GM, RGL), PPP1R3B (GL),
PPP1R3C (PTG, or protein targeting to glycogen), PPP1R3D (PPP1R6)
and PPP1R3E. PP1-GTS exhibit tissue and species-specific expression
and play critical roles in the hormonal regulation of cellular glycogen
metabolism [9e11].
Although present in low quantities, studies in murine models have
shown that adipose tissue can store glycogen [12,13]. Pp1r3c was
identified in a two-hybrid screen of a 3T3eL1 adipocyte library [14]
and, to date, remains the only reported PP1-GTS expressed in murine
adipocytes. Transgenic overexpression of PTG in adipose tissue in-
creases glucose flux into the glycogen synthesis pathway, indicating
that adipocytes are capable of storing high levels of glycogen.
Interestingly, although adipocyte function appeared to be maintained
in these animals, leptin, but not adiponectin, protein content in adi-
pose tissue was increased, and the associated hyperleptinemia was
independent of fat mass [15]. Further studies showed that upon
caloric excess-induced expansion of adipose tissue mass, the
elevated levels of glycogen in this model inhibited the mobilization of
triglyceride and impeded weight loss following the return to chow
feeding [16].
There is a paucity of research on the potential physio(patho)logical role
of glycogen metabolism in adipose tissue. We hypothesized that
obesity redirects glucose metabolic flux into glycogen synthesis in
human adipocytes. Here we show that hypoxia, which has been linked
to obesity-related adipose tissue dysfunction, increases glucose up-
take and stimulates glycogen synthesis in adipocytes. Glycogen-
loaded adipocytes exhibit increased autophagic flux, which directly
impacts their endocrine secretory function. Furthermore, enforced
glycogen deposition by overexpression of PTG in macrophages pro-
motes polarization towards the M1 pro-inflammatory phenotype.
Studies with human clinical samples confirm the interplay between
autophagy and glycogen storage and show that human obesity is
associated with glycogen deposition in adipocytes. Overall, our data
demonstrate that glycogen accumulation in adipocytes and macro-
phages contributes to adipose tissue inflammation, and might underlie
the metabolic alterations in obesity.6 MOLECULAR METABOLISM 5 (2016) 5e18  2015 The Authors. Published by Elsevier GmbH. This i2. METHODS
2.1. In vitro cell cultures
The SGBS cell line, provided by Dr. Wabitsch (University of Ulm, Ger-
many) and Lisa-2 cells, provided by Dr. Möller (University of Ulm,
Germany), were used as cellular models of human subcutaneous and
visceral pre-adipocytes, respectively, and were induced to differentiate
as described [17]. THP-1 cells (a human monocytic cell line; ATCC,
Rockville, MD) were induced to differentiate to macrophages with PMA
as previously described [18]. The human myogenic cell line LHCN-M2
was used as a cellular model of human myoblasts. For migration
experiments, monocytic THP-1 cells and Jurkat cells (human T cell
lymphoblast-like cell line; ATCC, Rockville, MD) were grown in sus-
pension. hASCs were isolated from the adipose tissue of lean patients
(BMI 22.5  0.3) following published protocols [19]. For hypoxia ex-
periments, fully differentiated cells were cultured in a modular incu-
bator flushed with 2% O2, 93% N2, and 5% CO2. As controls, cells
were cultured in a standard incubator (21% O2 and 5% CO2). Human
adipose tissue-derived macrophages were isolated from the stromal-
vascular fraction as previously described [20].
2.2. Adenoviral transduction
Cells were infected 7 days after induction of differentiation with an
adenovirus expressing murine PTG (Ad-PTG) [21] or GFP (Ad-GFP)
under the control of the CMV promoter [10]. Adenoviral infection was
carried out for 2 h at a multiplicity of infection (moi) of 50. One day after
infection, culture medium was depleted of insulin and FBS and
metabolic experiments were performed 24 h later.
2.3. Gene expression analysis
Total RNA was extracted from adipose tissue/cells using the RNeasy
Lipid Tissue Midi Kit (Qiagen Science, Hilden, Germany). Total RNA
quantity was measured at 260 nm and purity was assessed by the
OD260/OD280 ratio. One microgram of RNA was reverse transcribed
with random primers using the Reverse Transcription System (Applied
Byosistems, Foster City, CA). Quantitative gene expression was eval-
uated by Real-time PCR (qPCR) on a 7900HT Fast Real-Time PCR
System using TaqMan Gene Expression Assays (Applied Biosystems)
for in vitro experiments and TaqMan Low Density Arrays (Applied
Biosystems, microfluidic cards) for studies with human samples (See
Supplementary Experimental Procedures for all evaluated genes).
Results were calculated using the comparative Ct method (2-DDCt),
and expressed relative to the expression of the housekeeping genes
cyclophilin 1A (PPIA) (Hs 04194521_s1) and 18S (Hs 03928985_g1).
2.4. Glycogen synthesis rate
Cells were incubated with 20 mM [U-14C]glucose (0.05 mCi/mmol). To
extract glycogen, cell monolayers were scraped into 100 ml of 30% (w/
v) KOH and homogenates were boiled for 15 min. Homogenates were
spotted onto Whatman 3 MM paper, and glycogen was precipitated by
immersing the paper in ice-cold 66% (v/v) ethanol. Radioactivity in
dried papers was counted in a beta-radiation counter. Glycogen syn-
thesis rate was calculated as nanomoles of glucose incorporated per
milligram of protein, and results were expressed as the percentage of
stimulation over basal (control ¼ 100) [10].
2.5. Glycogen content determination
Cell monolayers were scraped in 30% (wt/vol.) KOH. Homogenates
were spotted onto Whatman 3 MM paper, and glycogen was precip-
itated in ice-cold 66% (vol./vol.) ethanol. The papers were incubated ins an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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0.4 mol/l acetate buffer, pH 4.8, with 0.833 mg/ml a-amyloglucosi-
dase (SigmaeAldrich, St. Louis, MO) for 120 min at 37 C. Glucose
release was measured with a glucose kit from Biosystems SA (Bar-
celona, Spain). Glycogen was also visualized in duplicate paraffin-
embedded tissue sections by the periodic acid/salicyloyl hydrazide
(PA-SH) method [22]. Half of the samples were incubated with alpha-
amylase (SigmaeAldrich, St. Louis, MO) for 10 min at 30 C as a
negative control. Other sections were stained with standard hema-
toxylin for histological examination.
2.6. Immunofluorescence detection of glycogen
Adipocytes grown on coverslips were fixed with 4% (w/v) para-
formaldehyde, rehydrated with 2% (v/v) fish skin gelatin, and per-
meabilized with 0.2% Triton X-100 prior to incubation with 5% (v/v)
goat serum. Subsequently, cells were incubated overnight at 4 C with
a monoclonal mouse anti-glycogen antibody in PBS containing 1%
goat serum. Coverslips were washed with PBS and incubated for 1 h at
room temperature with 1:100 Alexa Fluor 568 conjugated goat anti-
mouse followed by mounting with Pro Long Gold Antifade Reagent
with 40,6-diamidino-2-phenylindole, DAPI (Invitrogen Inc., Eugene OR).
Microscopy was performed with a Leica DM 4000B fluorescence mi-
croscope (Leica Microsystems, Wetzlar, Germany) and images were
captured with a Leica DFC 300 FX camera (Leica Microsystems). For
glycogen staining in human adipose tissue, freshly isolated fat depots
were fixed in 10% formalin and embedded in paraffin. Tissue sections
(5 mm) were deparaffinized and rehydrated, and immunofluorescence
detection of glycogen was performed as described above.
2.7. Transmission electron microscopy
Small human subcutaneous adipose tissue fragments (3 mm2) were
fixed with 2.5% paraformaldehyde, 1.5% glutaraldehyde in 0.1 M
phosphate buffer (pH 7.2) for 3e6 h at 4 C. Samples were then
washed for 3e12 h with the same buffer and postfixed with 1%
osmium tetroxide in the same buffer at 4 C for 1 h. Samples were
washed in water for 3e12 h and dehydrated in acetone, infiltrated with
Epon (Epon 812) resin for 2 days at room temperature, embedded in
the same resin and polymerized at 60 C for 48 h. Ultrathin sections
were obtained using a Leica (MZ6) Ultracut UCT ultramicrotome and
mounted on Formvar-coated copper grids. Sections were stained with
2% uranyl acetate in water and lead citrate. Then, sections were
examined and photographed using a JEM-1010 electron microscope
(Jeol, Japan).
2.8. Immunoblot analysis
Cells and human biopsies were lysed and homogenized in RIPA buffer
containing Protease Inhibitor Cocktail (SigmaeAldrich), and protein
concentration was determined with the BCA Protein Assay Kit (Pierce
Biotechnology, Boston, MA). Equal amounts of total protein were
separated on SDS-PAGE gels, transferred to Immobilon membranes
and blocked [23]. Immunoreactive bands were visualized with
SuperSignal West Femto chemiluminescent substrate (Pierce) and
images were captured using the VersaDoc imaging system and
Quantity One software (Bio-Rad, Hercules, CA).
2.9. Study selection and sample processing
Subjects were recruited by the Endocrinology and Surgery De-
partments at the University Hospital Joan XXIII (Tarragona, Spain) and
University Hospital Virgen de la Victoria (Málaga, Spain) in accordance
with the Declaration of Helsinki. Appropriate Institutional Review Board
approval and biobank informed consent was obtained from all par-
ticipants. Biobank samples included total and fractionated adiposeMOLECULAR METABOLISM 5 (2016) 5e18  2015 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comtissue from subcutaneous and visceral origin, serum and plasma. All
patients had fasted overnight before collection of blood and adipose
tissue samples. Plasma and serum samples were stored at 80 C
prior to performing measurements. See Supplementary Experimental
Procedures for further details.
2.10. Statistical analyses
Statistical analysis was performed with the Statistical Package for the
Social Sciences software, version 15 (SPSS, Chicago, IL). For in vitro
data, experimental results are presented as mean  SEM from 3 to 4
independent experiments performed at least in duplicate. Statistical
significance was tested with unpaired Student’s t test or one-way
ANOVA followed by the protected least-significant different test. For
clinical and anthropometrical variables, normal distributed data are
expressed as mean value  SD, and for variables with no Gaussian
distribution values are expressed as median (interquartile range). For
analysis of expression variables that do not have a Gaussian distri-
bution, values were analyzed by nonparametrical tests. Differences in
clinical variables, laboratory parameters, or expression variables be-
tween groups were compared using ANOVA with post hoc Scheffe
correction. Potential differences between depots were analyzed by
nonparametric paired-samples test (Wilcoxon test). Interactions be-
tween factors as well as the effects of covariates and covariate in-
teractions with factors were assessed by Pearson’s correlation
analysis and General Linear Model Univariate Analysis. Correction for
confounding and interacting variables was performed using stepwise
multiple linear regression analysis.
3. RESULTS
3.1. Hypoxia modulates extracellular glucose destination and
promotes glycogen accumulation in human adipocytes
Hypoxia has been proposed as an important stimulus for aberrant
adipose tissue inflammation and metabolism in obesity [24e26], and
provides a good model system to study mechanisms of obesity-linked
adipocyte dysfunction. It has been recently shown that hypoxia might
influence glucose metabolism in adipocytes to prevent oxidative
damage [27]. Similar to the findings in other cellular models of obesity-
associated insulin resistance [28e31], we found that glucose uptake is
increased in SGBS adipocytes subjected to hypoxia (Figure 1A). This
increase in glucose uptake correlates with significantly greater mRNA
expression of glucose transporters GLUT1 and GLUT4 and a non-
significant increase in GLUT3 expression (Figure 1B). To determine
whether glucose metabolism was altered by hypoxia, we measured
[13C]-enrichment in human adipocytes incubated with uniformly
labeled [U-13C]-glucose or natural abundance glucose. Nuclear mag-
netic resonance (NMR) spectroscopy of lipid extracts from adipocytes
cultured in hypoxia and normoxia revealed a similar incorporation of
[13C] into lipid structures (Normoxia: 1.29%  0.06 vs. Hypoxia:
1.20%  0.03). Also, no significant differences were detected in the
relative total lipid content between the two conditions (Figure S1).
However, mass spectrometry (MS) metabolic profiling of aqueous
extracts from adipocytes subjected to hypoxia or normoxia unexpect-
edly revealed that intracellular levels of glucose, the glycolysis end
product pyruvate, and the tricarboxylic acid (TCA) cycle intermediate
succinate, were all significantly reduced in hypoxia-cultured cells
(Figure 1C). Despite the differences in the pool size of these metab-
olites, the percentage of [13C]-labeled metabolites arising from
[U-13C]-glucose did not differ between normoxia and hypoxia treat-
ments (Figure S2). Given that high glucose uptake in hypoxia-cultured
human adipocytes appeared not to be related to lipid biosynthesis orn access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 7
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least-significance different test.
Original articleTCA activity, we hypothesized that glucose metabolism might be
redirected to glycogen synthesis. We therefore evaluated the impact of
hypoxia on glycogen synthesis in adipocytes by measuring the rate of
incorporation of radioactively labeled glucose into glycogen after a
period of glucose deprivation. Hypoxia enhanced extracellular glucose
deposition into glycogen (Figure 1D). Accordingly, analysis of glycogen
content using the a-amyloglucosidase method revealed significant
increases in intracellular glycogen in hypoxic SGBS and Lisa-2 adi-
pocytes (Figure 1E). Increased glycogen content was also observed in
hypoxia-cultured mature adipocytes obtained by differentiation of hu-
man adipose-derived stem cells (hASCs), as demonstrated by immu-
nocytochemistry with a glycogen antibody (Figure 1F). Furthermore,
intracellular levels of glycogen significantly decreased in SGBS and
Lisa-2 adipocytes following 24 h of glucose deprivation, whereas
stimulation with glucose and insulin increased glycogen accumulation
(Figure S3). These data show that adipocytes can dynamically regulate
their glycogen content in response to glucose availability and obesity-
related stress conditions.8 MOLECULAR METABOLISM 5 (2016) 5e18  2015 The Authors. Published by Elsevier GmbH. This i3.2. Glycogen deposition in adipocytes modifies their endocrine
function via an autophagy-dependent mechanism
To examine whether glycogen accumulation might lead to metabolic
changes in human adipocytes, we overexpressed the glycogen-
targeting subunit PTG in SGBS cells by adenoviral infection. Analysis
of glycogen levels (Figure 2A) and immunofluorescence staining with
an antibody to glycogen (Figure 2B) demonstrated substantial glycogen
deposition in PTG-expressing SGBS adipocytes but not in control (Ad-
GFP) cells. Glycogen synthase protein levels were increased in Ad-PTG
expressing cells, which correlated with a reduction in its inactive form
(P-GS-Ser641) (Figure 2C). We also observed a decrease in glycogen
phosphorylase (GP) protein expression in Ad-PTG expressing cells
(Figure 2C). Thus, enforced expression of PTG increases glycogen
synthesis and might inhibit glycogen degradation. Data from murine
models reveal that enhancement of adipocyte glucose flux into
glycogen exerts specific effects on the expression of leptin but not
adiponectin [15]. To determine whether glycogen accumulation influ-
enced the endocrine function of human adipocytes, we first analyzeds an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Original articleadipokine and cytokine gene expression in Ad-PTG transduced cells.
Compared with control cells, mRNA expression of leptin, IL1-beta and
TNF-alpha increased significantly upon PTG overexpression, whereas
adiponectin, MCP-1 and IL-6 gene expression decreased significantly
(Figure 2D). Among these genes, however, only leptin, IL-1beta and
adiponectin showed a similar pattern of gene expression and protein
secretion (Figure 2E). Consistent with the increase in leptin expression,
conditioned medium from PTG-overexpressing cells (adip-CM)
enhanced the migratory capacity of human monocytic THP-1 cells and
Jurkat T cells (Figure 2F). To test whether these changes in endocrine
function might also modulate insulin sensitivity, we next assessed
insulin signaling in glycogen-loaded adipocytes. Insulin-induced
phosphorylation of insulin receptor substrate-1 (IRS-1), Akt and
p70S6K was significantly blunted in Ad-PTG-transduced adipocytes
relative to equivalent Ad-GFP cells (Figure 2G). A similar result was
obtained in human myocytes cultured for 24 h with adip-CM
(Figure 2G). Basal adipocyte metabolism was unaffected by glycogen
accumulation since similar cellular respiratory rates, metabolic gene
expression and lactate release were observed in glycogen-loaded
adipocytes and control cells (Figure S4). Nevertheless, an increase
in the sensitivity to the lipolytic agents isoproterenol and CL-316243
was evident in glycogen-loaded adipocytes (Figure 2H), supporting0.0
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We next sought to explore the potential mechanism(s) by which
glycogen accumulation alters the endocrine function of adipocytes. In
this context, increasing evidence from diverse model systems sug-
gests a dynamic regulatory cross-talk between autophagy and
glycogen metabolism [33]. Intriguingly, forced glycogen deposition in
Ad-PTG-expressing human adipocytes led to an increase in autophagic
flux as revealed by the increased expression of key autophagy-related
proteins including GABARAPL1 and L3CBII (Figure 3A). No differences,
however, were observed between Ad-PTG cells and Ad-GFP cells in the
expression of starch-binding domain-containing protein 1 (STBD1),
which has been directly related to autophagic degradation of glycogen
particles with aberrant branching (termed glycophagy) [34,35].
Moreover, ER stress markers (GRP78, CHOP) and NF-kB signaling
components (IkBa and IkBb) were unchanged in PTG overexpressing
cells (Figure 3A). Unexpectedly, this apparent activation of autophagy
in glycogen-loaded adipocytes was associated with an inhibition of
AMPK and mTORC1 signaling. Consequently, we detected a decrease
in the expression of the active form of mTOR and phosphorylation of its
downstream targets, p70S6K and ULK1, in Ad-PTG adipocytes relative
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Original articleTSC2 phosphorylation at the Thr1462 residue, we observed a decrease
in P-PRAS40 levels (Thr246), suggesting that mTORC1 regulation
might be dependent on PRAS40 regulation (Figure 3B). We therefore
used the mTOR activator MHY1485 [36] to question whether glycogen-
induced autophagy is dependent on mTORC1 inhibition. The increase
in mTOR-induced ULK1 phosphorylation at Ser758 detected in the
presence of MHY1485 was associated with a decrease in L3CBII
expression (Figure 3C). Finally, to examine a potential role for auto-
phagy in the regulation of leptin production by glycogen accumulation,
we utilized 3-methyladenine (3-MA) as a pharmacological inhibitor of
autophagy [37]. Incubation of human adipocytes with 3-MA blocked
the PTG-induced expression of GABARAPL1 (Figure 3D), but not
glycogen accumulation (Figure 3E). Notably, 3-MA treatment had no
effect on the PTG-induced increase in leptin gene expression but
inhibited its secretion (Figure 3F), supporting the accumulating evi-
dence that autophagy serves as a new mechanism to control protein
trafficking and secretion [38]. Taken together, these results highlight
the glycogen-autophagy intersection as a novel regulatory mechanism
of leptin secretion in human adipocytes and suggest that modulation of
glycogen levels in human adipocytes might modify their endocrine
functions, contributing to adipose tissue inflammation and systemic
insulin resistance.
3.3. Glycogen levels control the pro-inflammatory state of adipose
tissue and promote macrophage M1 polarization
To study the in vivo function of PTG in adipose tissue inflammation, we
first analyzed the inflammatory gene expression profile in adipose
tissue from PTG KO mice and wild-type (WT) littermates [32].
Consistent with the link suggested between PTG overexpression and
the pro-inflammatory state (Figure 2), PTG KO mice display reduced
expression of several inflammatory gene markers in adipose tissue
relative to WT mice (Figure S5). Differences in the expression of some
of these genes (mainly MCP-1 and IL-6) between human cellular and
murine models could be a consequence of comparing adipocytes
(human cells) with whole adipose tissue (murine model). Because
inflammatory responses in adipose tissue are dynamically regulated
through innate immune cells, we further explored the effects of
glycogen accumulation on the metabolic state and phenotype of hu-
man THP-1 macrophages. First, we confirmed that, similar to human
adipocytes (Figure 1D), hypoxia enhanced extracellular glucose
deposition in macrophages into glycogen (Figure 4A). Also, mirroringTable 1 e Anthropometric and biochemical variables in the two cohorts studie
First cohort
Lean Ob
N 19 37
Sex (male/female) 13/6 22/15
Age (years) 51.68  15.96 58.58
BMI (kg/m2) 23.11  1.59 29.07
Waist (cm) 83.7  7.9 99.29
DBP (mmHg) 68.47  9.90 76.4
SBP (mmHg) 121.47  11.77 135.84
Glucose (mmol/L) 4.33  0.68 5.56
Cholesterol (mmol/L) 5.19  1.18 5.10
HDLc (mmol/L) 1.46  0.21 1.35
Triglycerides (mmol/L) 1.15  0.53 1.17
Insulin (mIU/ml) 4.52  3.44 6.71
HOMA-IR 1.11  0.84 1.74
The results are given as the mean  SD. BMI: body mass index; DBP: Diastolic Blood Pres
resistance index. a indicate significant differences between the means of the different grou
12 MOLECULAR METABOLISM 5 (2016) 5e18  2015 The Authors. Published by Elsevier GmbH. This iour observations in adipocytes (Figure 2BeC), PTG overexpression
increased intracellular glycogen levels in THP-1 macrophages
(Figure 4B), correlating with enhanced GS activity and decreased GP
expression (Figure 4C). Since macrophages can adopt different acti-
vation states (classical M1 or alternative M2 activation) [39], we
assessed whether enforced glycogen deposition influenced macro-
phage polarization. We analyzed M1 and M2 gene expression markers
in Ad-PTG M0 (unactivated) macrophages and control cells (Ad-GFP
M0). We observed an increase in the classical M1 markers IL-1b and
MCP-1 in parallel with a decrease in the M2 markers Arg1 and IL-10 in
glycogen-loaded M0 cells (Figure 4D). Moreover, monocyte and
lymphocyte migration was increased with conditioned medium (CM)
from PTG-overexpressing macrophages compared with CM from
control cells (Figure 4E). More importantly, and consistent with pub-
lished reports [40], we found that the commitment of glycogen-loaded
M0 macrophages to the M1 phenotype was also evident in the
metabolic gene expression profile, which was directed towards
glycolysis (Figure 4F) and lactate release (Figure 4G). Furthermore, we
detected an increase in the TCA cycle intermediate succinate, which
has recently been associated with enhanced glycolysis and IL-1b
secretion [41] (Figure 4H). Consistent with an increase in TCA activity,
glycogen-loaded macrophages showed higher succinate dehydroge-
nase (SDHB) and alpha-ketoglutarate dehydrogenase (OGDH) gene
expression (Figure 4I). Interestingly, although similar cellular respira-
tory rates were observed, a decrease in residual oxygen consumption
(ROX) was detected in Ad-PTG macrophages compared with Ad-GFP
macrophages, suggesting that the mitochondrial: non mitochondrial
respiration ratio might be increased in Ad-PTG M0 macrophages
(Figure 4J).
3.4. Altered expression of glycogen metabolic genes correlates
with autophagy gene expression in human obesity
To determine whether obesity and insulin resistance altered glycogen
metabolism in human adipose tissue, we analyzed several glycogen-
related metabolic genes (Supplementary Experimental Procedures) in
a well-characterized human cohort (clinical and laboratory data
summarized in Table 1). We found a significant reduction in the
expression of glucan (1,4-alpha) branching enzyme 1 (GBE1) and PP1-
GTS 3E (PPP1R3E) mRNA in the subcutaneous adipose tissue (SAT) of
obese subjects (Figure 5A). Bivariate analysis revealed that GBE1 gene
expression levels correlated negatively with body mass index (BMI),d for mRNA and protein expression levels.
Second cohort
ese Lean Obese
10 38
5/5 16/22
 13.21 42.90  10.70 41.97  11.91
 3.02a 23.29  1.33 42.39  14.57a
 14.33a 83.15  6.78 116.22  25.5a
 11.77b 78.80  19.62 79.14  12.98
 16.90b 110.10  21.94 131.11  18.26a
 0.49a 4.77  0.63 5.19  0.63
 0.95 5.32  1.06 5.12  1.01
 0.29 1.52  0.39 1.26  0.36
 0.66 1.11  0.58 1.45  0.69
 4.94 6.75  2.67 15.87  11.56a
 1.35 1.40  0.48 3.81  2.83b
sure; SBP: Systolic Blood Pressure. HOMA-IR: homeostasis model assessment of insulin
ps: a: p < 0.001: b: p < 0.01 (Student t test).
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Figure 5: Human obesity is associated with changes in adipose glycogen metabolism and autophagy gene expression. (A) GBE1 and PPP1R3E mRNA expression in SAT
depots of subjects from the first cohort (n ¼ 56) divided into two groups according to BMI (lean: BMI<25 and obese: BMI>25). *p < 0.01 vs. lean. (B) Correlation between SAT
GBE1 and PPP1R3E mRNA expression and clinical variables. (C) GABARAPL1 and ULK1 mRNA expression in SAT depots of subjects from the first cohort. (D) Bivariate correlations
between glycogen metabolic genes (GBE1 and PPP1R3E) and ULK1. (E) PPP1R3B, PPP1R3C, PPP1R3D, PPP1R3E mRNA expression in SAT and VAT depots from the first cohort
(n ¼ 56). (F) PPP1R3C and PPP1R3E mRNA expression in SAT and VAT depots compared to skeletal muscle (SM) (n ¼ 9) *p < 0.05. (G) PPP1R3C and PPP1R3E and (H) GBE1
mRNA expression in isolated adipocytes (AD) and stromal vascular fraction (SV) from SAT and VAT (n ¼ 6; paired adipose biopsies). *p < 0.01. Data comparisons were made by
Kruskal Wallis test for multiple groups and Mann Whitney test for two groups. Potential differences between depots were analyzed by nonparametric paired-samples test (Wilcoxon
test). Interactions between factors as well as the effects of covariates and covariate interactions with factors were assessed by Pearson’s correlation analysis and General Linear
Model Univariate Analysis. Data are presented as median with interquartile range (A and C) and as mean  SEM (E, F, G and H). *p < 0.01.whereas PPPR13E was negatively associated with waist circumference
and weight (Figure 5B). Given the relationship found between glycogen
metabolism and autophagy in vitro, we analyzed the gene expression
profile of autophagy-related genes in the same cohort (Supplementary
Experimental Procedures). Interestingly, SAT depots from obese in-
dividuals exhibited lower mRNA levels of GABARAPL1 and ULK1
(Figure 5C). Additionally, consistent positive correlations were foundMOLECULAR METABOLISM 5 (2016) 5e18  2015 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.combetween glycogen metabolic genes (GBE1 and PPP1R3E) and ULK1
mRNA expression (Figure 5D). More importantly, multiple regression
analysis adjusting for age and gender revealed that ULK1 predicts
GBE1 (B ¼ 0.548; P < 0.001) and PPP1R3E (B ¼ 0.649; P ¼ 0.001)
gene expression in SAT. To date, PTG (PPP1R3C) is the only reported
PP1-GTS expressed in murine adipocytes (15). Of note, we found that
PPP1R3E was the most predominant PP1-GTS isoform in human VATn access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 13
Original articleand SAT depots (Figure 5E). Indeed, PPPR13E mRNA is highly
expressed in adipose tissue (VAT and SAT) relative to human skeletal
muscle (Figure 5F), where a high level of this isoform was previously
demonstrated [23]. In addition, we confirmed that PPP1R3E mRNA is
found predominantly in mature adipocyte cells in human adipose tissue
and not in other cells from the stromal-vascular (SV) pool (Figure 5G).
Similarly, GBE1 is essentially restricted to mature adipocytes, with a
lower signal in the SV fraction (Figure 5H). As a whole, our in vivo
observations consolidate a significant association between glycogen
metabolism and autophagy in human adipocytes.
3.5. Human obesity is associated with enhanced protein levels of
GS and glycogen stores in adipose tissue
To validate our gene expression data, we performed protein expression
studies in a selected number of subjects from a second independentF
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by transmission electron microscopy (TEM). Glycogen is visualized as small dark granules (b
adipocytes isolated from SAT of lean (n ¼ 9) and obese (n ¼ 10) subjects using a-amylog
one-way ANOVA followed by the protected least significance different test. (I) Bivariate co
expression (Pearson’s correlation analysis).
14 MOLECULAR METABOLISM 5 (2016) 5e18  2015 The Authors. Published by Elsevier GmbH. This icohort (clinical and laboratory data summarized in Table 1), in which
circulating leptin levels were confirmed to be higher in obese subjects
than in lean individuals (58.49  7.10 vs. 19.96  10.98 pg/ml). In
agreement with mRNA levels, obese subjects presented a significant
reduction in GBE1 and PPP1R3E protein expression in the SAT depot
compared with lean subjects (Figure 6A). Although we found no sig-
nificant differences in mRNA expression, obesity was also associated
with greater levels of GS protein in SAT (Figure 6A). To explore a
potential link between glycogen metabolism in adipose tissue and
insulin sensitivity, obese subjects from the second cohort were clas-
sified according to their insulin resistance assessed by HOMA-IR. No
significant differences were found in GBE1 protein expression between
both groups (low IR vs. high IR); however, obese patients with high
HOMA-IR values (>3.2) presented a significant decrease in PPP1R3E
protein expression in SAT depots compared with patients with lowD
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e immunoblotting of GBE1, PPP1R3E and GS protein expression in SAT from subjects of
obese, Ob: BMI>25, n ¼ 7). GAPDH was used as a loading control. Quantification is
of GBE1, PPP1R3E and GS protein expression in SAT of obese subjects (Ob) classified
A-IR<3.2 and high insulin resistance (high IR): HOMA-IR>3.2). GAPDH was used as a
presentative immunoblotting of GBE1 protein expression in isolated adipocytes (AD) and
d as a loading control. Quantification is shown (n ¼ 4). *p < 0.05 vs. lean subjects. (D)
acid-Schiff (PAS) staining for glycogen. Pretreatment with a-amylase eliminated PAS-
rrows indicate macrophage-like structures. (E) Glycogen immunofluorescence (red) on
h DAPI (blue). (F) Representative glycogen immunofluorescent detection in SAT biopsies
own. ATMs (black arrows). (G) Glycogen detection in SAT from lean and obese subjects
lack arrows). Representative images are shown (n ¼ 6). (H) Glycogen content in mature
lucosidase method. Statistical significance was tested with unpaired Student’s t test or
rrelations between glycogen content in mature adipocytes and BMI and Leptin mRNA
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values (HOMA-IR<3.2). Furthermore, we found significantly greater GS
protein expression in the SAT depot of those insulin-resistant subjects
(Figure 6B). Nevertheless, we found no differences in GS protein
expression in lean subjects stratified as low/high IR (Figure S6),
suggesting that alterations in GS might be related more to adiposity
than to insulin resistance status. Importantly, the significant increase in
GS protein expression was detected both in adipocytes and SV cells
from SAT of obese subjects (Figure 6C). Further, we used different
methodological approaches to assess whether human obesity could be
related to changes in fat glycogen storage. Periodic acid-Schiff (PAS)
staining of glycogen in SAT depots revealed an increase in total cellular
glycogen in obese subjects, both in adipocytes and ATMs (Figure 6D).
Immunofluorescent staining of glycogen in isolated macrophages from
lean and obese subjects (Figure 6E), as well as in SAT depots
(Figure 6F), confirmed these findings. Moreover, transmission electron
microscopy (TEM) of fat tissue from biopsy specimens demonstrated
that glycogen could be detected as small dark granules in the cyto-
plasm of subcutaneous adipocytes from obese patients (Figure 6G).
Finally, we quantified glycogen content using the a-amyloglucosidase
method in mature adipocytes isolated from SAT depots of lean and
obese subjects. A significant increase of glycogen levels was detected
in obese mature adipocytes (Figure 6H). Additionally, bivariate analysis
revealed a positive association between glycogen content and BMI and
also leptin expression (Figure 6I). Collectively, our results establish that
adipose tissue glycogen deposition may underlie whole-body meta-
bolic alterations found in human obesity.
4. DISCUSSION
Glucose is one of the major energy substrates for adipose tissue
metabolism, and functional integrity of this organ in terms of glucose
uptake is crucial for regulating intermediate metabolism [42,43]. Un-
like skeletal muscle and liver, where glucose can be converted to
glycogen (glycogenesis), it is thought that in adipose tissue, glucose is
used mainly to provide energy or to supply glycerol phosphate for
triacylglycerol synthesis [43]. Surprisingly, the potential role of
glycogen metabolism in human adipose tissue and its effect on adi-
pose tissue dynamics has received little attention.
Adipose tissue expansion in response to positive energy balance can
lead to a myriad of local effects, including hypoxia [44]. Here we
demonstrate that a redirection of glucose flux to glycogen synthesis
occurs as a response to hypoxia in human adipocytes and macro-
phages, and we provide evidence that glycogen accumulation results
in a damaging metabolic and secretory profile in these cells. We
postulate that the increase of basal glucose uptake observed in
obesity-linked conditions, such as hypoxia (this study) [45], hyper-
insulinemia [28], pro-inflammatory cytokine activation [46,47] or
endoplasmic reticulum stress [48], might be associated with a redi-
rection of glucose metabolism to glycogenesis.
Our study provides insights into the metabolic consequences of
glycogen overcapacity in human adipose tissue. Adipocyte glycogen
accumulation provokes damaging effects as previously demonstrated
in several cell types including neurons and retinal pigment epithelium
[49e51]. Thus, enforced glycogen deposition modifies the adipocyte
secretion pattern to one that is characterized by a decrease in the anti-
inflammatory adipokine adiponectin and an increase in leptin secre-
tion, in agreement with previous findings in PTG-transgenic mice [15].
Leptin is a potent chemoattractant for monocytes, neutrophils and
dendritic cells [52e55], and also activates the expression of other pro-
inflammatory cytokines [54]. Consequently, deleterious effects in
terms of insulin sensitivity and immune cell recruitment were detectedMOLECULAR METABOLISM 5 (2016) 5e18  2015 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comin PTG-expressing adipocytes. Contrary to the in vivo data from aP2-
PTG transgenic mice [16], we observed higher rates of lipolysis in
glycogen-loaded adipocytes, which, combined with their altered
secretory profile, might contribute to the insulin resistant state asso-
ciated with obesity. Critically, glycogen accumulation has a pro-
inflammatory effect in macrophages. Accordingly, enforced glycogen
deposition in inactive macrophages increases pro-inflammatory gene
expression, glycolysis and succinate release, reflective of an M1
phenotype as previously described [41]. Together, our data identifies
glycogen as an inflammatory metabolic signal in adipose tissue.
Of note, we report for the first time a new regulatory glycogen-
autophagy crosstalk mechanism controlling leptin secretion in hu-
man adipocytes, which bolsters emerging discoveries linking auto-
phagy to biosynthetic processes [32] and cytokine release [56].
Generally activated by nutrient deprivation, autophagy flux in glycogen-
loaded adipocytes correlates with a negative regulation of the nutrient-
sensing kinase mTOR, which has been previously associated with
autophagy activation [57], but not with ER stress or NFKb signaling, as
detected in other cellular systems [58,59]. In fact, inhibition of
mTORC1 is sufficient to induce autophagy in the presence of nutrients
[60]. Unexpectedly, glycogen-loaded adipocytes did not display dif-
ferences in TSC2 phosphorylation, but a decrease in P-PRAS40
(Thr246), an upstream negative regulator of mTORC1 [61], was
observed suggesting that mTORC1 regulation in our model might be
produced in a TSC2-independent, PRAS40-dependent, manner.
PRAS40 phosphorylation could be AKT-dependent or eindependent
[62], and additional studies are needed to elucidate the mechanism by
which glycogen accumulation controls mTORC1 activity. Remarkably,
the presence of a glycogen sensor in the mTOR pathway has also been
recently suggested in liver, where glycogen has been revealed as an
important coordinator of glucose and lipid metabolism [32].
It is also noteworthy that although AMPK-mTOR-Ulk1/2 metabolic
cross-talk is considered an important regulator of autophagy [63], we
found that the accumulation of glycogen in human adipocytes and
subsequently autophagy activation is associated with mTORC1 but also
AMPK inactivation. However, the glycogen-binding domain on the
AMPKb subunit has been revealed as a regulatory domain that inhibits
AMPK phosphorylation by upstream kinases [64] and Ulk1 might also
directly phosphorylates and inactivates AMPK [65]. Accordingly, it is
not unreasonable to suggest a model where adipocytes may sense
pathological accumulation of glycogen through an mTORC1 mecha-
nism independent of AMPK. The fact that adipocytes from an obese
context behave as if they are in a nutrient and energy deprivation state
suggests a disturbance in some cellular energetic sensor and point to
mTORC1 signaling as a key regulator of adipocyte metabolism in
pathological conditions.
Intriguingly, the proposed networking of glycogen with autophagy is
also observed in human adipose tissue with implications for obesity.
Interestingly, and contrary to murine models [15], our data establish
PPP1R3E as the major PP1-GST isoform expressed in human adipo-
cytes, and PTG (PPP1R3C) is mainly found in the SV fraction. Similar to
PTG, PPP1R3E overexpression results in glycogen accumulation in
SGBS adipocytes (Figure S7). Obese subjects display an obvious in-
crease in glycogen deposition in adipocytes, which correlates with a
decrease in GBE1 and PPP1R3E, but more importantly with an increase
of GS protein expression. Indeed, obese patients with the highest
degree of insulin resistance present the highest protein levels of GS.
Remarkably, glycogen content in mature adipocytes positively corre-
lates with BMI and leptin expression, supporting the link found in vitro
between adipocyte glycogen and leptin. The reduced levels of some
glycogen metabolic genes detected in obese adipose tissue mayn access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 15
Figure 7: Adipose tissue glycogen accumulation as a potential trigger of obesity-linked inflammation in humans. In the context of human obesity, adipocytes and ATMs
exhibit a redirection in glucose metabolism to glycogen synthesis (glycogenesis). Glycogen-loaded adipocytes present an increased autophagic flux, which, in turn, directly impacts
their secretory function, encouraging immune cell recruitment and insulin resistance. Additionally, glycogen deposits in inactivated (M0) macrophages promotes M1 polarization,
suggesting that adipose tissue glycogen might be a metabolic inflammatory signal in human obesity. L ¼ lipid droplet; N ¼ nucleus; G ¼ glycogen accumulation; GS ¼ glycogen
synthase.
Original articlerepresent the onset of a counter regulatory mechanism as a defense
against the pathological accumulation of glycogen in adipocytes. On
the other hand, the correlation observed between several markers of
glycogen synthesis and autophagy supports the link between both
processes. Thus, ULK1 was revealed as one of the main determinants
of GBE1 and PPP1R3E mRNA expression in SAT depots and was
downregulated in obese subjects. We hypothesize that the reduction in
GABARAPL1 and ULK1 gene expression detected in our cohorts might
represent a compensatory mechanism for autophagy induction
described in obese and diabetic patients [66e69].
In conclusion, this study provides the first evidence of adipose tissue
glycogen as an inflammatory signal, which might underlie the patho-
genesis of obesity and insulin resistance. We postulate that in an
obesity setting, a shift from glycolytic metabolism to glycogenesis
occurs in adipose tissue, which directly determines the secretory
function of adipocytes by a mechanism dependent on autophagy flux
activation, as well as an increase in the M1 polarized macrophage
population (Figure 7). Whether glycogen mishandling is a primary
disturbance or an indirect consequence of obesity is difficult to
establish at the present time and awaits further investigation. None-
theless, our study suggests metabolic disturbance in adipocytes as a
potential primary event in obesity-related inflammation that should be
considered in the development of new therapeutic strategies to alle-
viate obesity-associated metabolic disorders.
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